SKBA Capital Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.08M Sell
33,510
-1,210
-3% -$261K 0.97% 46
2025
Q4
$7.13M Sell
34,720
-12,030
-26% -$2.26M 1.01% 46
2025
Q3
$7.34M Sell
46,750
-9,700
-17% -$1.5M 1.01% 47
2025
Q2
$9.48M Sell
56,450
-1,615
-3% -$240K 1.36% 41
2025
Q1
$8M Buy
58,065
+815
+1% +$104K 1.19% 45
2024
Q4
$6.77M Sell
57,250
-49,550
-46% -$5.78M 1.07% 48
2024
Q3
$11.8M Sell
106,800
-50
-0% -$5.23K 1.75% 24
2024
Q2
$10.5M Sell
106,850
-800
-0.7% -$81.5K 1.69% 25
2024
Q1
$12M Sell
107,650
-200
-0.2% -$21.6K 1.88% 25
2023
Q4
$10.9M Sell
107,850
-25,800
-19% -$2.56M 1.83% 24
2023
Q3
$11.6M Sell
133,650
-14,100
-10% -$1.27M 2.14% 16
2023
Q2
$14M Sell
147,750
-50
-0% -$4.22K 2.52% 9
2023
Q1
$11.2M Hold
147,800
2.08% 16
2022
Q4
$11.4M Sell
147,800
-22,850
-13% -$1.74M 2.1% 16
2022
Q3
$11.4M Buy
170,650
+1,000
+0.6% +$63.4K 2.41% 12
2022
Q2
$8.87M Sell
169,650
-43,700
-20% -$2.48M 1.77% 29
2022
Q1
$12.1M Sell
213,350
-45,800
-18% -$2.45M 2.18% 16
2021
Q4
$13.3M Buy
259,150
+69,770
+37% +$3.42M 2.51% 10
2021
Q3
$9.37M Buy
189,380
+14,700
+8% +$797K 1.87% 24
2021
Q2
$9.97M Sell
174,680
-47,600
-21% -$2.78M 1.95% 22
2021
Q1
$13.5M Buy
222,280
+16,280
+8% +$899K 2.14% 18
2020
Q4
$11M Buy
206,000
+106,900
+108% +$5.55M 1.85% 26
2020
Q3
$4.65M Sell
99,100
-6,300
-6% -$323K 0.93% 54
2020
Q2
$5.5M Sell
105,400
-1,100
-1% -$56.7K 1.07% 46
2020
Q1
$5.11M Hold
106,500
1.16% 39
2019
Q4
$5.39M Sell
106,500
-22,800
-18% -$1.18M 0.85% 49
2019
Q3
$6.1M Buy
+129,300
New +$5.9M 0.97% 45
2018
Q2
Sell
-96,400
Closed -$6.04M 78
2018
Q1
$6.04M Sell
96,400
-500
-0.5% -$34.3K 0.82% 53
2017
Q4
$5.94M Sell
96,900
-5,540
-5% -$343K 0.83% 52
2017
Q3
$6.86M Buy
102,440
+9,600
+10% +$679K 0.99% 47
2017
Q2
$7.23M Sell
92,840
-11,200
-11% -$845K 1.09% 41
2017
Q1
$8.48M Sell
104,040
-11,160
-10% -$878K 1.13% 39
2016
Q4
$8.29M Buy
+115,200
New +$8.33M 0.98% 43
2016
Q1
Sell
-146,865
Closed -$13.1M 85
2015
Q4
$13.1M Sell
146,865
-27,900
-16% -$2.37M 1.33% 39
2015
Q3
$13.4M Sell
174,765
-1,500
-0.9% -$125K 1.15% 38
2015
Q2
$14.7M Sell
176,265
-7,300
-4% -$645K 1.15% 38
2015
Q1
$16.6M Sell
183,565
-2,000
-1% -$172K 1.29% 36
2014
Q4
$15M Buy
185,565
+100
+0.1% +$7.9K 1.15% 39
2014
Q3
$13.9M Buy
185,465
+12,900
+7% +$939K 1.15% 38
2014
Q2
$11.8M Sell
172,565
-2,500
-1% -$170K 1.05% 40
2014
Q1
$12.3M Buy
175,065
+23,400
+15% +$1.63M 1.14% 41
2013
Q4
$10.1M Sell
151,665
-19,400
-11% -$1.19M 1.18% 39
2013
Q3
$8.92M Sell
171,065
-16,200
-9% -$823K 1.08% 43
2013
Q2
$8.84M Buy
+187,265
New +$8.55M 1.04% 44

Other funds holding CAH

SKBA Capital Management's CAH Position: Q1 2026 in Review

SKBA Capital Management reduced its Cardinal Health (CAH) stake by 3.5% in Q1 2026, selling an estimated $261K and leaving 33,510 shares worth $7.08M. The position accounts for 0.97% of the portfolio, ranked #46.

SKBA Capital Management first reported a position in CAH in Q2 2013 and has held it in 44 quarters since. The position peaked at $16.6M in Q1 2015. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • SKBA Capital Management held 33,510 shares of Cardinal Health worth $7.08M as of Q1 2026.
  • SKBA Capital Management sold 1,210 Cardinal Health shares in Q1 2026, an estimated $261K.
  • Cardinal Health made up 0.97% of SKBA Capital Management's portfolio in Q1 2026, its #46 holding.
  • SKBA Capital Management first reported a position in Cardinal Health in Q2 2013 and has held it in 44 quarters since.
  • SKBA Capital Management's Cardinal Health position peaked at $16.6M in Q1 2015.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on SKBA Capital Management's 13F filing for Q1 2026, filed 13 May 2026.